Peli BioThermal收购Evo以加强细胞和基因治疗物流的低温运输能力Peli BioThermal Acquires Evo to Enhance Cryogenic Shipping for Cell and Gene Therapy Logistics

动脉网2025-10-08

by Mark Chiang马克·蒋Share To分享到Peli BioThermal has acquired Evo, a company specializing in cryogenic shipping and tracking technology, to expand its portfolio in temperature-controlled logistics. The ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2574908487?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-08 23:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2574908487","market":"us","top_or_hot":-1,"title":"Peli BioThermal收购Evo以加强细胞和基因治疗物流的低温运输能力Peli BioThermal Acquires Evo to Enhance Cryogenic Shipping for Cell and Gene Therapy Logistics","media":"动脉网","content":"<div>\n<p>by Mark Chiang马克·蒋Share To分享到Peli BioThermal has acquired Evo, a company specializing in cryogenic shipping and tracking technology, to expand its portfolio in temperature-controlled logistics. The ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008235008a4574b34&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peli BioThermal收购Evo以加强细胞和基因治疗物流的低温运输能力Peli BioThermal Acquires Evo to Enhance Cryogenic Shipping for Cell and Gene Therapy Logistics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeli BioThermal收购Evo以加强细胞和基因治疗物流的低温运输能力Peli BioThermal Acquires Evo to Enhance Cryogenic Shipping for Cell and Gene Therapy Logistics\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-08 23:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008235008a4574b34&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>by Mark Chiang马克·蒋Share To分享到Peli BioThermal has acquired Evo, a company specializing in cryogenic shipping and tracking technology, to expand its portfolio in temperature-controlled logistics. The ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008235008a4574b34&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PELI","symbol_name":"Pelican Acquisition Corp","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008235008a4574b34&s=b","article_id":"2574908487","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008235008a4574b34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2574908487","pubTimestamp":1759938420,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"此次收购旨在增强 Peli BioThermal 在制药价值链中的能力，特别是在支持细胞和基因治疗物流方面。Evo’s expertise in cryogenic shipping solutions and advanced tracking systems will complement Peli BioThermal’s existing offerings. By incorporating Evo’s technology, Peli BioThermal plans to strengthen its ability to manage temperature-sensitive shipments critical for CGT therapies. These therapies often require precise temperature control during transportation to maintain their efficacy.Evo在低温运输解决方案和先进追踪系统方面的专业知识将与Peli BioThermal的现有产品形成互补。通过整合Evo的技术，Peli BioThermal计划增强其管理对CGT疗法至关重要的温控运输能力。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PELI":"Pelican Acquisition Corp"},"translate_title":"Peli BioThermal acquires Evo to strengthen cryogenic shipping capabilities for cell and gene therapy logistics Peli BioThermal Acquires Evo to Enhance Cryogenic Shipping for Cell and Gene Therapy Logistics","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PELI":0.9},"content_text":"by Mark Chiang马克·蒋Share To分享到Peli BioThermal has acquired Evo, a company specializing in cryogenic shipping and tracking technology, to expand its portfolio in temperature-controlled logistics. The acquisition aims to enhance Peli BioThermal’s capabilities across the pharmaceutical value chain, particularly in supporting cell and gene therapy (CGT) logistics.Peli BioThermal 收购了专注于低温运输和追踪技术的公司 Evo，以扩展其在温控物流领域的业务组合。此次收购旨在增强 Peli BioThermal 在制药价值链中的能力，特别是在支持细胞和基因治疗（CGT）物流方面。This move is expected to drive innovation and integration within the cold chain sector..此举有望推动冷链行业的创新和整合。Evo’s expertise in cryogenic shipping solutions and advanced tracking systems will complement Peli BioThermal’s existing offerings. By incorporating Evo’s technology, Peli BioThermal plans to strengthen its ability to manage temperature-sensitive shipments critical for CGT therapies. These therapies often require precise temperature control during transportation to maintain their efficacy.Evo在低温运输解决方案和先进追踪系统方面的专业知识将与Peli BioThermal的现有产品形成互补。通过整合Evo的技术，Peli BioThermal计划增强其管理对CGT疗法至关重要的温控运输能力。这些疗法在运输过程中通常需要精确的温度控制以保持其有效性。The acquisition reflects an ongoing effort by Peli BioThermal to address growing demands for reliable cold chain solutions within the pharmaceutical industry..此次收购反映了Peli BioThermal为满足制药行业对可靠的冷链解决方案不断增长的需求而持续努力。Newsflash | Powered by GeneOnline AI新闻快讯 | 由GeneOnline AI提供支持Source: GO-AI-ne1来源：GO-AI-ne1For any suggestion and feedback, please contact us.如果有任何建议和反馈，请联系我们。Date: October 8, 2025日期：2025年10月8日Related posts:相关内容：Biosimilar Insulin: Lower-Cost Alternatives With Same Active Ingredients Offer Potential for Improved Diabetes Access生物类似胰岛素：具有相同活性成分的低成本替代品为改善糖尿病治疗提供了可能Lifestyle Changes Essential for Long-Term Weight Loss After Medication.药物治疗后，生活方式的改变对长期减肥至关重要。Global Surge in Dietary Supplement Use Drives Demand for Tailored Health Solutions全球膳食补充剂使用的激增推动了对定制健康解决方案的需求Study Identifies Link Between Gut Microbiota, Genes, and Severity of Ulcerative Colitis研究发现肠道微生物群、基因与溃疡性结肠炎严重程度之间存在联系©www.geneonline.com All rights reserved. Collaborate with us:©www.geneonline.com 保留所有权利。与我们合作：[email protected][email protected]Author作者Mark Chiang马克·江Related Post相关文章News Flash新闻快讯Estonian Biobank Study Identifies Genetic Variants Linked to Body Mass Index爱沙尼亚生物银行研究发现与身体质量指数相关的基因变异2025-10-082025年10月8日","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2574908487","isCrawlerRequest":true}